Key role of the P2Y1 receptor in tissue factor-induced thrombin-dependent acute thromboembolism: Studies in P2Y1-knockout mice and mice treated with a P2Y1 antagonist

Circulation

Volumn 103, Issue 5, 2001, Pages 718-723

  Léon, Catherine ^a   Freund, Monique ^a   Ravanat, Catherine ^a   Baurand, Anthony ^a   Cazenave, Jean Pierre ^a   Gachet, Christian ^a  

^a INSERM   (France)

Author keywords

Adenosine diphosphate; Drugs; Platelets; Receptors; Thrombosis

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; HIRUDIN; N6 METHYL 2' DEOXYADENOSINE 3',5' DIPHOSPHATE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE RECEPTOR; THROMBOCYTE RECEPTOR P2Y1; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; THROMBOCYTE COUNT; THROMBOEMBOLISM;

EID: 0035814760     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.5.718     Document Type: Article

References (41)

1. Platelet-coagulant protein interactions
2. Mechanisms involved in platelet procoagulant responses
3. Effect of SR121566A, a potent GPIIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo
4. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human 7E3 antibody
5. The basic pharmacology of ticlopidine and clopidogrel
6. Clopidogrel hydrogenosulfate
7. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
8. Importance of platelets in experimental venous thrombosis in the rat
9. Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat
10. ADP receptors on platelets
11. Participation of ADP in the binding of fibrinogen to thrombin-stimulated platelets
12. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates
13. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PARD activating peptide through the late activation of phosphoinositide 3-kinase
14. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets
15. ADP receptors and clinical bleeding disorders
16. 1 receptor
17. 1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate
18. 1 receptor is necessary for ADP-induced platelet aggregation
19. 1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
20. 1 purinoceptor in ADP-induced platelet activation
21. i2 proteins
22. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
23. Molecular basis for ADP-induced platelet activation, I: Evidence for three distinct ADP receptors on human platelets
24. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel
25. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
26. 1 receptor-null mice
27. 1-deficient mice
28. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species
29. Mouse antithrombotic assay: A simple method for the evaluation of antithrombotic agents in vivo: Potentiation of antithrombotic activity by ethyl alcohol
30. Mouse antithrombotic assay: Inhibition of platelet thromboembolism by disintegrins
31. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation
32. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma: Its inhibition by heparin
33. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice
34. Activated human protein C prevents thrombin-induced thromboembolism in mice
35. Endothelial control of the cardiovascular system: Recent advances
36. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
37. P2 receptor subtypes in the cardiovascular system
38. 1 antagonist, inhibits ADP-induced platelet aggregation in vitro and ex vivo and prolongs the bleeding time
39. Experimental gram-negative septicemia: Thromboplastin generation in mononuclear phagocytes from different anatomical sites
40. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity
41. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats